launch
Pharma

As RevMed preps for ‘historic’ cancer launch, questions linger

An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years.
Darren Incorvaia Aug 27, 2026 11:27am
Takeda

Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo

Aug 28, 2026 10:04pm
Mounjaro

FDA approves Lilly's Mounjaro to reduce risk of cardio events

Aug 28, 2026 10:52am
Podcast
Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a

MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check

Aug 28, 2026 10:07am
social media app

Biogen platforms lupus patient advocate in social media push

Aug 28, 2026 9:34am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K

Aug 28, 2026 9:30am
More News
Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

Aug 28, 2026 9:17am

Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia

Aug 28, 2026 9:00am

ESC: Cytokinetics data is first to demonstrate benefit for nHCM

Aug 28, 2026 5:50am

Omnicom PR consultancy injects new leadership into pharma push

Aug 28, 2026 4:41am